PATENT CLAIM ANALYSIS

Application Number: 16161705
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-01
Patent Classification: ["536", "026120"]

Abstract:
Disclosed herein are nucleotide analogs, methods of synthesizing nucleotide analogs and methods of treating diseases and/or conditions such as a HCV infection with one or more nucleotide analogs.

Claim (Index 32):
The compound of  claim 30 , wherein R 1  is methyl.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 97.0
- Lexical Diversity: 1.25
- Patent Class: 536.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15256337', '14135488', '14135484', '15256345', '15790764']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7672007249937526
- 35 USC 102 Novelty (BERT): 0.5796316447062583
- Combined Prediction Score: 0.7484438169650032
- Mean Citation Score: 609.9594500000002
- Max Citation Score: 641.41254
- Similarity Product: 370.176176184597

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test